About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

CHUGAI PHARMACEUTICAL CO., LTD.(4519) Summary

4519
TSE Prime
CHUGAI PHARMACEUTICAL CO., LTD.
6,718
JPY
+359
(+5.65%)
Apr 10, 3:30 pm JST
45.76
USD
Apr 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
5.81
Yield
3.72%
Margin Trading Ratio
5.77
Stock Price
Apr 10, 2025
Opening Apr 10, 9:09 am
6,759 JPY 45.89 USD
Previous Close Apr 9
6,359 JPY 43.74 USD
High Apr 10, 9:24 am
6,804 JPY 46.26 USD
Low Apr 10, 12:43 pm
6,631 JPY 45.01 USD
Volume
2,542,800
Trading Value
0.02T JPY 0.12B USD
VWAP
6707.32 JPY 45.72 USD
Minimum Trading Value
671,800 JPY 4,576 USD
Market Cap
11.28T JPY 0.08T USD
Number of Trades
7,348
Liquidity & Number of Trades
As of Apr 10, 2025
Liquidity
High
1-Year Average
6,096
1-Year High Oct 28, 2024
21,781
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 38,100 473,200 12.42
Mar 28, 2025 41,400 453,900 10.96
Mar 21, 2025 54,200 463,600 8.55
Mar 14, 2025 45,800 441,500 9.64
Mar 7, 2025 70,800 384,600 5.43
Company Profile
CHUGAI PHARMACEUTICAL CO., LTD. is a major pharmaceutical company. As a subsidiary of Roche, it has expanded its product line, including Tamiflu. The company's main focus is on anticancer drugs and rheumatoid arthritis treatments.
Sector
Pharmaceuticals
CHUGAI PHARMACEUTICAL CO., LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and sales of pharmaceuticals, operating under the Swiss pharmaceutical giant Roche. In Japan, the company sells its own products through authorized dealers, while overseas it has sales bases in Europe, Taiwan, China, and other regions. Manufacturing is carried out at the company's domestic and international factories, as well as through contracted partners. As a member of the Roche Group, Chugai purchases some raw materials from Roche and distributes some products internationally through Roche's network. The company focuses on developing innovative drugs, particularly in the fields of cancer treatment and rheumatoid arthritis, while pursuing global business expansion.